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We examined the contribution of endothelial relaxing factors and potassium channels in actions of CPCA, potent adenosine A2
receptor agonist, on isolated intact male rat femoral artery (FA). CPCA produced concentration-dependent relaxation of FA,
which was notably, but not completely, reduced after endothelial denudation. DPCPX, A1 receptor antagonist, had no signiﬁcant
eﬀect,whileSCH58261(A2A receptorantagonist)notablyreducedCPCA-evokedeﬀect.Pharmacologicalinhibitionofnitricoxide
synthaseorcyclooxygenase comparablyreducedCPCA-evokedaction,stillinalesserdegreethanafterdenudation.Inthepresence
of buﬀer with high K+ (100 mM), CPCA-produced relaxations were almost abolished. TEA (nonselective KCa blocker), gliben-
clamide (KATP blocker), Ba++ (KIR blocker), or ouabain (Na+/K+-ATPase inhibitor) did not change CPCA-induced relaxation.
Concentration-response curve for CPCA was signiﬁcantly shifted to the right after the incubation of apamin (SK channel blocker).
CPCA produced concentration-dependent relaxation of FA that was partly dependent on endothelial cells. Endothelium-related
portion of CPCA-elicited eﬀect was mediated by combined action of endothelial NO, prostacyclin, and EDHF after activation of
endothelial A2A receptors. Small conductance KCa channels were involved in this action.
1.Introduction
Adenosine is an endogenous purine nucleoside with wide
distribution in almost every tissue. It is involved in ﬁne ad-
justments of numerous physiological functions [1], includ-
ing vascular tone of diﬀerent blood vessels [2]. It has been
described that local ischemia can induce the release of this
nucleoside, which can further modulate vascular resistance
and increase oxygen distribution. The vascular eﬀects of ade-
nosine are generally exerted through activation of adenosine
receptors, namely, A1,A 2A,A 2B,a n dA 3 receptors, producing
contractionorrelaxation,thisdependingonexaminedblood
vessel. Vasodilatations in response to adenosine are predom-
inantly due to activation of adenosine A2 receptors locat-
ed on vascular smooth muscle or endothelial cells [3–8].
Endothelium-independent relaxant eﬀect of adenosine has
been demonstrated in guinea pig coronary artery [9], rat in-
ferior mesenteric artery [10], or feline pulmonary artery
[11]. On the other hand, adenosine-induced endothelium-
dependent relaxations have been recorded in rabbit pulmo-
naryartery[12],ratrenalartery[13],orporcinecoronaryar-
tery [14].
Femoral arteries are vital blood vessels allowing blood
ﬂow and oxygen supply to the muscles and superﬁcial tissues
oflegs.However,theyaresusceptibletotheperipheralarteri-
al disease, mainly through atherosclerotic process [15]. Tak-
ing into account that actions of adenosine and various ago-
nists of adenosine receptors in femoral arteries of diﬀerent
species are still under investigation, the present experiments
were undertaken in order to (1) examine isolated male2 The Scientiﬁc World Journal
rat femoral artery response to CPCA—potent A2 receptor
agonist—[16], (2) evaluate possible contribution of func-
tional endothelium in vascular eﬀects of CPCA, (3) deter-
mine contribution of endothelial relaxing factors in CPCA-
induced action on femoral artery, and (4) examine if potas-
sium ion channels or Na+/K+-ATPase is involved in eﬀects of
used agonist.
2.MaterialsandMethods
ThestandardsfromtheEuropeanConventionfortheProtec-
tion of Vertebrate Animals Used for Experimental and Other
Scientiﬁc Purposes, as well as guidelines from the Good
Laboratory Practice, were fully applied in regard to proce-
dureswithusedanimals.Themethodologyusedinthisstudy
was in accordance with our previous investigations [10, 13].
Brieﬂy, the femoral artery was isolated from male Wistar rats
(220–280g), carefully dissected from surrounding fat and
connective tissue, cut into circular segments (which were
4mm long), and immediately placed in the Krebs-Ringer
bicarbonate solution (composition in mM: NaCl 118.3, KCl
4.7, CaCl2 2.5, MgSO4 1.2, KH2PO4 1.2, NaHCO3 25.0,
Ca-EDTA 0.026; glucose 11.1). The endothelium was re-
moved from some rings by gently rubbing the intimal sur-
face with stainless-steel wire. Vascular rings were mounted
between two stainless-steel triangles in an organ bath con-
taining, Krebs-Ringer bicarbonate solution (37◦C, pH 7.4)
and aerated with 95% O2 and 5% CO2. One of the trian-
gles was attached to a displacement unit allowing a ﬁne
adjustment of tension and further connected to a force-dis-
placement transducer (Hugo Sachs Elektronik F30 Type 372,
Freiburg, Germany). Isometric tension was continuously re-
corded on a Rikadenki R-62 multipen electronic recorder
(Rikadenki Kogyo CO., Ltd., Tokyo, Japan).
At the beginning of each experiment, endothelium’s
functional integrity was examined by precontraction of iso-
lated femoral artery with submaximal concentration (EC50–
EC70) of phenylephrine, followed by the addition of acetyl-
choline (1μM). This procedure was repeated three times in
20min intervals (Figure 1). Relaxation >80% of phenyle-
phrine precontraction was indicative for functionally intact
endothelium. The morphological integrity of vascular endo-
thelium was additionally conﬁrmed at the end of randomly
selected experiments by preparing histological preparations
of rat femoral artery with standard haematoxylin and eos-
in staining (Figure 2). Concentration-response curves for
CPCA were obtained in a cumulative fashion on phenyle-
phrine-precontracted arteries. Since separate experiments in
preparations of femoral artery demonstrated that the ﬁrst
and the second concentration-response curves (determined
45min apart) for CPCA were not signiﬁcantly diﬀerent, a
multiplecurvedesignprotocolwasapplied(Figure1).There-
after, all pharmacological blockers were incubated during
30min prior the second concentration-response curve.
The eﬀect induced by each concentration of CPCA was
expressed as a relaxation percentage of phenylephrine pro-
ducedprecontraction.Theresultswereexpressedasmeans ±
SEM. and n refers to the number of experiments. The con-
centration of CPCA producing 50% of its own maximum
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Figure 1: Original recording of CPCA-produced cumulative vascu-
lar response of isolated rat femoral artery. A multiple curve design
protocol was applied, since the preliminary experiments on prepa-
rationsoffemoralartery(n = 4)demonstratedthattheﬁrstandthe
second concentration-response curve (determined 45min apart)
for CPCA were not signiﬁcantly diﬀerent. Ach: acetylcholine; Phe:
phenylephrine.
response (EC50) was determined by using a nonlinear least
square ﬁtting procedure of the individual experimental data
and was presented as pEC50 (pEC50 =− log EC50). All cal-
culations were done by using the computer program Graph
Pad Prism (Graph Pad Software Inc., San Diego, calif, USA).
Statistical signiﬁcance of diﬀerences between two means was
determined with paired Student’s t-test. A value of P<0.05
was considered to be statistically signiﬁcant.
The following chemicals were used: 5 -(N-cyclopro-
pyl) carboxyamidoadenosine (CPCA), indomethacin, 1,3-
dipropyl-8-cyclopentylxanthine(DPCPX),7-(2-phenylethyl)-
5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]
pyrimidine SCH 58261, L-phenylephrine, ouabain, gliben-
clamide (Sigma, St Louis, USA, Mo); acetylcholine iodide,
tetraethylammonium bromide (TEA) (Serva, Heidelberg,
Germany); NG-nitro-L-arginine (L-NOARG) (RBI, Natick,
Mass, USA); apamin, BaCl2 (ICN, Irvine, Calif, USA). All
agents (except as described below) were dissolved in distilled
water and diluted to the desired concentration with buﬀer.
Indomethacin was dissolved in equimolar Na2CO3 solution,
glibenclamide was dissolved in 1,2-propylenglycol, DPCPX
was dissolved in DMSO with NaOH, and CPCA stock solu-
tion was initially prepared in 0.01MHCl. Preliminary ex-
periments in preparations of rat femoral artery demon-
strated that the vascular action of CPCA was unaﬀected by
used dissolvents. The experiments with ouabain were per-
formed in a dark room. During the experimental procedure,
all agents were added directly to the organ bath in a volume
of 150μL, and the concentrations given are the calculated
ﬁnal concentrations in the bath solution.
3. Results
CPCA (0.1–100μM) produced concentration-dependent
relaxation of intact rat femoral artery. After the endothelial
denudation control relaxations induced by CPCA wereThe Scientiﬁc World Journal 3
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Figure 2: Histological preparations of rat femoral artery with (a), and without (b) endothelial cell layer (hematoxyline and eosin staining,
magniﬁcation = 400x).
Table 1: CPCA-induced relaxation in isolated rat femoral artery in the absence or in the presence of the speciﬁc pharmacological
intervention. Concentration of CPCA eliciting 50% of its own maximum response (EC50) is presented as pEC50 (pEC50 =− log EC50),
whereas maximal obtained relaxation is expressed as a percentage of the precontraction produced by phenylephrine. Each result represents
the mean ± SEM (n = 4 −7).
Pharmacological intervention pEC50 ±SEM Max (%) ± SEM Pharmacological intervention pEC50 ±SEM Max (%) ± SEM
Denudation (−)5 .91 ±0.17 102.56 ±2.56 TEA (−)6 .05 ±0.18 96.34 ±0.97
Denudation (+) 4.79 ±0.38
∗ 54.01 ±2.22
∗ TEA (+) 6.30 ±0.18 85.50 ±13.30
DPCPX (−)5 .99 ±0.27 96.66 ±5.89 Apamin (−)5 .90 ±0.19 96.97 ±3.03
DPCPX (+) 5.88 ±0.23 89.94 ±7.62 Apamin (+) 5.47 ±0.25
∗ 91.67 ±8.33
SCH 58261 (−)5 .71 ±0.42 97.9 ±2.09 Glibenclamide (−)5 .84 ±0.45 101.92 ±1.92
SCH 58261 (+) 5.46 ±0.12
∗ 56.35 ±1.84
∗ Glibenclamide(+) 5.76 ±0.26 89.28 ±6.83
L-NOARG (−)6 .03 ±0.25 114.42 ±8.11 Ba++ (−)6 .13 ±0.42 99.98 ±0.49
L-NOARG (+) 5.51 ±0.35
∗ 78.81 ±4.62
∗ Ba++ (+) 6.01 ±0.38 95.32 ±3.94
Indomethacin (−)5 .82 ±0.26 109.37 ±4.13 Ouabain (−)6 .09 ±0.26 100.49 ±1.12
Indomethacin (+) 5.96 ±0.24 72.25 ±5.62
∗ Ouabain (+) 6.12 ±0.28 104.32 ±2.18
High K+ (−)5 .92 ±0.39 97.94 ±1.09
High K+ (+) 4.70 ±0.04
∗ 18.76 ±3.13
∗
∗P<0.05 compared to the respective control (paired Student’s t-test).
signiﬁcantly reduced (P<0.01; Table 1 and Figure 3(a)). Ap-
plication of DPCPX (10nM), adenosine A1 receptor antag-
onist, had no signiﬁcant eﬀect on intact femoral artery
relaxation elicited by CPCA (P>0.05; Table 1). On the other
hand, SCH 58261 (adenosine A2A receptor antagonist, 1μM)
signiﬁcantly reduced CPCA-evoked relaxation (P<0.01;
Table 1 and Figure 3(b)). Moreover, the maximal relaxant ef-
fect of CPCA after the incubation of SCH 58261 was compa-
rable with the one obtained after the endothelial denudation
(P>0.05).
Individual incubations of L-NOARG (NO-synthase in-
hibitor,10μM)andindomethacin(cyclooxygenaseinhibitor,
10μM) produced signiﬁcant and comparable inhibitions of
intact rat femoral artery response to CPCA (Table 1 and
Figures 3(c) and 3(d)). Nevertheless, the reduction of max-
imal relaxant eﬀects, recorded after the incubation of L-
NOARG or indomethacin, was less pronounced if compared
totheoneobtainedaftertheendothelialdenudation(Table1;
P<0.05).
In the presence of buﬀer with high potassium (KCl =
100mM) CPCA-induced relaxation on intact vascular rings
was strongly inhibited (P<0.01; Table 1 and Figure 4(a)).
Moreover, control concentration-response curve for CPCA
was slightly, but signiﬁcantly and shifted to the right after the
incubation of 2μM apamin (small conductance KCa channel
blocker; P<0.05; Table 1 and Figure 4(b)). Oppositely, TEA
(K+ channel blocker applied in a concentration of 500μM
selective for large conductance KCa channels), glibenclamide
(KATP channel blocker, 1μM), Ba++ (KIR channel blocker,
3μM), or ouabain (Na+/K+-ATPase inhibitor, 100μM) did
not change control relaxations induced by CPCA on exam-
ined blood vessel (P>0.05; Table 1).
4. Discussion
In our investigation, CPCA induced concentration-depend-
ent relaxant response in intact vascular rings of rat femo-
ral artery. In accordance, bolus injections of adenosine or4 The Scientiﬁc World Journal
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Figure 3: CPCA-induced relaxation in isolated rat femoral artery after the endothelial denudation or in the presence of SCH 58261, N
G-
nitro-L-arginine (L-NOARG), or indomethacin. Each point represents the mean ± SEM. (n = 4−7). Vascular relaxations induced by CPCA
are expressed as percentages of the precontraction induced by phenylephrine. ∗P<0.05 and ∗∗P<0.01 compared to the control relaxant
eﬀect (n = number of vessels).
CPCA into the femoral artery of rabbit produced dose-de-
pendent increase in femoral blood ﬂow and decrease in
resistance[17].Aftertheendothelialdenudation,CPCA-pro-
duced relaxation in our experiments was notably, yet not
completely reduced. Thus, it could be proposed that the
eﬀect of CPCA is partly dependent upon intact endothelial
cells and feasible release of endothelial relaxing factors.
Moreover, it can be also suggested that a signiﬁcant part of
CPCA vascular action is most probably induced by direct ac-
tion on speciﬁc binding sites located on smooth muscle cells.The Scientiﬁc World Journal 5
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Figure 4: CPCA-induced relaxation in isolated rat femoral artery in the presence of hyperpolarizing solution (KCl = 100mM) or apamin.
Each point represents the mean ± SEM. (n = 5–7). Vascular relaxations induced by CPCA are expressed as percentages of the precontraction
induced by phenylephrine. ∗P<0.05 and ∗∗P<0.01 compared to the control relaxant eﬀect (n = number of vessels).
In order to characterize the subtype of adenosine recep-
tors associated with CPCA action, we used DPCPX and SCH
58261, adenosine A1 and A2A receptor antagonists, respec-
tively. As expected, DPCPX did not change control concen-
tration-response curves for CPCA, thus, excluding possible
contribution of adenosine A1 receptors in femoral artery re-
sponse to the used agonist. This ﬁnding is also supported
by the previous result that vasodilatation of the rat femoral
artery induced by 2-octynyladenosine (YT-146), an adeno-
sine A2 receptor agonist, was not antagonized by DPCPX
[18]. On the other hand, in our investigation SCH 58261 sig-
niﬁcantly reduced CPCA-evoked relaxant eﬀect. Moreover,
the maximal relaxant action of CPCA after the incubation
of SCH 58261 was statistically comparable with the one ob-
tained after the endothelial denudation. This is indicative
for the presumption that the endothelium-dependent part of
CPCA-evoked action is most probably initiated by predom-
inant CPCA binding to adenosine A2A receptors located on
endothelialcells.Furthermore,itisreasonabletosuggestthat
the endothelium-independent part of the CPCA-produced
eﬀect was probably associated with activation of another ad-
enosine A2 receptor subtype, most likely A2B, which is locat-
ed on smooth muscle cells. This hypothesis needs further
evaluation.
In the next part of our study, it was of interest to evalu-
ate possible contribution of endothelial nitric oxide and
prostacyclin in vascular response to CPCA. Thus, CPCA-
evoked relaxation was notably reduced by L-NOARG. This
was in accordance with partial inhibition of rat femoral ar-
tery response to 2-octynyladenosine (YT-146), adenosine A2
receptor agonist, obtained in another investigation after the
incubation of L-NNA (also an NO-synthase inhibitor) [18].
Moreover, in a diﬀerent study NO-synthase inhibition in-
duced by L-NAME greatly reduced the increase in femoral
vascular conductance evoked by CGS 21680, agonist of ad-
enosine A2A receptors [19]. However, in our experiments
the reduction recorded after incubation of L-NOARG was
less pronounced if compared with the one obtained after
endothelial denudation. This suggests that endothelial nitric
oxide is only partially involved in endothelium-dependent
fraction of the transduction mechanism involved in rat fem-
oral artery response to CPCA. Concurrently, based on addi-
tionally performed experiments with indomethacin, the
same presumption can be proposed regarding the involve-
ment of endothelial prostacyclin.
The corresponding analysis of previous results showed
that endothelial nitric oxide and prostacyclin equally contri-
buted to CPCA-induced relaxation of investigated blood ves-
sel. Moreover, as mentioned earlier, the obtained reduction
in the presence of L-NOARG or indomethacin was signif-
icantly lower than that after endothelial denudation. This
wasindicativefortheassumptionthatseparateendothelium-
dependent component of CPCA-evoked eﬀect was not com-
pletely mediated by nitric oxide or prostacyclin. Thus, we
hypothesized that some other endothelial relaxing factor,
presumably endothelium-derived hyperpolarizing factor
(EDHF), may be involved in CPCA-induced eﬀect. This as-
sumption was conﬁrmed in our experiments in which po-
tassium conductance was blocked by buﬀer with high K+
(100mM) resulting in strong inhibition of the CPCA-in-
duced relaxation. Thus, it can be proposed that EDHF no-
tably contributed to the endothelium-dependent fraction of6 The Scientiﬁc World Journal
CPCA action. However, if we take into account that the inhi-
bition in the presence of high potassium buﬀer was more
pronounced than the one recorded after endothelial denuda-
tion, it can be assumed that, apart from the indirect action
mediated via EDHF, a signiﬁcant part of CPCA eﬀect was
actually a result of direct action on smooth muscle cells and
subsequent increase of cellular membrane potassium con-
ductance. Although this suggestion requires secondary ex-
perimental assessment, in our recent investigation on femor-
al artery we obtained that adenosine-induced relaxation was
endothelium-independentandfullyinhibitedinthepresence
of a buﬀer with high K+ [20].
In general, EDHF-mediated vascular eﬀects can be exert-
ed through activation of Na+/K+-ATPase or diﬀerent potas-
sium channels [21–23]. In our study, TEA (potassium chan-
nel blocker applied in a concentration selective for large
conductance calcium-activated potassium channels—BKCa),
glibenclamide (ATP-sensitive potassium channel blocker—
KATP), Ba++ (inward-rectifying potassium channel blocker—
KIR), or ouabain (Na+/K+-ATPase inhibitor) did not change
control relaxations induced by CPCA on examined blood
vessel. This excluded the possible role of blocked pharmaco-
logical targets in femoral artery relaxant response to CPCA.
On the other hand, the control pEC50 value for CPCA-
produced concentration-response curve was signiﬁcantly re-
duced after the incubation of apamin, which suggests certain
roleofsmallconductancecalcium-activatedpotassiumchan-
nels (SK) in studied vasorelaxant process.
In conclusion, CPCA produced concentration-depend-
ent relaxation of isolated rat femoral artery that was partly
dependent on endothelial cells. Endothelium-related part of
the CPCA-elicited eﬀect was mediated by combined action
of endothelial nitric oxide, prostacyclin, and EDHF after
predominant activation of endothelial adenosine A2A recep-
tors. Small conductance KCa channels were involved in trans-
duction mechanism of CPCA-induced vascular response
on examined blood vessel. It appears that endothelium-
independent portion of CPCA-evoked relaxation of rat
femoral artery did not involve adenosine A2A receptors. This
direct eﬀe c to fC P C Ao ns m o o t hm u s c l ec e l l sw a sm o s tl i k e -
ly dependent upon activation of adenosine A2B receptors
and subsequent increase of cellular membrane potassium
conductance. However, these assumptions need further
clariﬁcation.
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